Navigation Links
Celleration Inc. Announces Award-Winning Clinical Results to Reduce Unfavorable Deep Tissue Injury Outcomes
Date:3/3/2011

EDEN PRAIRIE, Minn., March 3, 2011 /PRNewswire/ -- Celleration Inc., a privately held medical device company focused on developing and commercializing therapeutic ultrasound healing technologies, announced the release of award-winning clinical results at the 2011 National Pressure Ulcer Advisory Panel (NPUAP) Biannual meeting in Las Vegas using MIST® Ultrasound Healing Therapy. The clinical results using MIST Therapy to treat deep tissue injuries(DTI), a form of pressure ulcer or bed sore, were so compelling that the poster was awarded NPUAP's top award for contribution to the field of pressure ulcer research.

The retrospective analysis was conducted at Central Baptist Hospital in Lexington, Kentucky and included 85 patients with a total of 127 deep tissue injuries.  The control group received standard of care, while the treatment group added MIST Therapy to the standard of care.  In the MIST Therapy group 80% demonstrated a favorable outcome, while only 22% of the control group demonstrated a favorable outcome. There was a complete reversal of favorable to unfavorable outcomes between the two groups.  Joyce Black, Associate Professor in the College of Nursing at the University of Nebraska Medical Center and Past President of the NPUAP states, "Deep tissue injury is recognized today as the cause of some of the worse pressure ulcers we see. We had come to believe that there was not much we could do to reverse the tissue loss, but the Central Baptist data should cause all of us to rethink our treatments for DTI."

MIST Therapy is a noncontact, low frequency ultrasound that is delivered through a saline mist.  Unlike conventional wound treatments that are limited to treating the surface, MIST Therapy delivers energy deep into the wound bed to rescue injured cells and minimize tissue loss through reducing inflammation and promoting the body's normal healing process.  "We are very pleased with the results of MIST Therapy in treating deep tissue injuries and the ability of MIST to provide a treatment solution where none has previously existed," stated Mark Wagner, CEO of Celleration.  

A deep tissue injury (DTI) is a type of pressure ulcer that results in injury deep below the surface, but is not visible until days later. The injury then progresses very rapidly to a deep, open wound called a Stage III or IV pressure ulcer, which is considered an unfavorable outcome.  DTI's are a common occurrence in US hospitals with average prevalence rates of 7% to 9%.  In 2008, the Center for Medicare Services (CMS) stopped paying for hospital-acquired conditions they felt were the results of poor quality care, commonly known as "never events".  Stage III and IV pressure ulcers, a common outcome of deep tissue injuries, are included on the list of "never events".

For more information go to www.celleration.com


'/>"/>
SOURCE Celleration
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Celleration, Inc. Announces Close of $8 Million Series E Financing
2. Insmed Announces European Medicines Agency Acceptance of Its Pediatric Investigation Plan for ARIKACE™ in the Cystic Fibrosis Pseudomonas Indication
3. Kendle Announces Fourth Quarter and Full-Year 2010 Results
4. InstaCare Announces Receipt of Technology and Patent Value Analysis Penned by Joseph Wolf, Ph.D and William Walling, CFA
5. Naviscan Announces European Launch of Positron Emission Mammography
6. CVS Caremark Announces Agreement With ActiveHealth Management for Evidence-Based Clinical Decision Support
7. Handa Pharmaceuticals Announces Submission of Its First-to-File ANDA for Takedas DEXILANT®
8. Sangamo BioSciences Announces Presentation at the Cowen and Company 31st Annual Health Care Conference
9. An Easier Way to Breathe Better - ICAP Ocean Tomo Announces an Advanced Medical Inhaler Design
10. Perrigo Announces Arrival of the FDA for Reinspection Related to the Allegan Facility Warning Letter
11. Volcano Corporation Announces Webcast of March 9th Analyst Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , Belgium , June 24, ... VNRX), today announced the appointment of Dr. ... Directors as a Non-Executive Director, effective June 23, ... Audit, Compensation and Nominations and Governance Committees.  As ... Futcher will provide independent expertise and strategic counsel ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... their offering. The current ... environment for MedImmune to enter. The US ageing population creates ... drive considerable growth for effective anti-influenza medications. The introduction of ... but development is still in its infancy. ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway ... call for a minimum wage raise to $12 an hour by 2020 and then adjusting ... restore the lost value of the minimum wage, assure the wage floor does not erode ...
Breaking Medicine News(10 mins):